Mesenchymal Stromal Cells Can Be Derived From Bone Marrow CD133 + Cells: Implications for Therapy
- 1 April 2009
- journal article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 18 (3) , 497-510
Abstract
It is known that the bone marrow (BM) CD133 + cells play an important role in the hematopoietic compartment, but this is not their only role. The cells indeed can take part in vascular reconstitution when they become endothelial cells (EC), in skeletal muscle fiber regeneration when there is a switch in muscle precursors, and to cardiomyocyte phenotypic conversion when differentiating in cardiomyocytes-like cells. While the role in hematopoiesis and vasculogenesis of the selected cells is well established, their ability to differentiate along multiple non-EC lineages has not yet been fully elucidated. The goal of this study is to assert whether human CD133 + BM-derived cells are able to differentiate in vitro, besides to blood cells, cell lineages pertinent to the mesoderm germ layers. To this end, we isolated CD133 + cells using a clinically approved methodology and compared their differentiation potential to that of hematopoietic progenitor cells (HPCs) and mesenchymal stem cells (MSCs) obtained from the same BM samples. In our culture conditions, CD133 expression was consistently decreased after passage 2, as well as the expression of the stemness markers c-kit and OCT4, whereas expression of Stage Specific Embryonic Antigen 4 (SSEA4) remained consistent in all different conditions. Expanded CD133 were also positive for HLA-ABC, but negative for HLA-DR, in accordance with what has been previously reported for MSCs. Moreover, CD133 + cells from human BM demonstrated a wide range of differentiation potential, encompassing not only mesodermal but also ectodermal (neurogenic) cell lineages. CD133 antigen could be potentially used to select a cell population with similar characteristics as MSCs for therapeutic applications.Keywords
This publication has 53 references indexed in Scilit:
- De novo isochromosome 18p in two patients: cytogenetic diagnosis and confirmation by chromosome paintingClinical Genetics, 2008
- Nomenclature of prominin‐1 (CD133) splice variants – an updateTissue Antigens, 2007
- Telomere and telomerase in stem cellsBritish Journal of Cancer, 2007
- Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCsBlood, 2007
- Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and PlasticityStem Cells, 2005
- A New Human Somatic Stem Cell from Placental Cord Blood with Intrinsic Pluripotent Differentiation PotentialJournal of Experimental Medicine, 2004
- Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In VitroStem Cells, 2004
- Characterization of a Lineage‐Negative Stem‐Progenitor Cell Population Optimized for Ex Vivo Expansion and Enriched for LTC‐ICStem Cells, 2004
- Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrowBlood, 2002
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002